Zieo Pharma has become aware that Bioverativ has filed complaints in the Indian. District Court for the District of Delaware and with the International Trade Commission....
Learn MoreZieo today announced that the U.S. Food and Drug Administration (FDA) has approved Zieo Behring’s HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), the only subcutaneous therapy indicated for...
Learn MoreZieo to acquire an 80 per cent stake in plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (“Ruide”) in China for US$352 million...
Learn MoreAs the CEO of a biopharma company that is focused on innovation for patients, I was struck recently by the scientific thinking and discovery happening at an event that....
Read OnMacular degeneration. Glaucoma. Diabetic retinopathy. These are among the diseases that are causing 61 million Americans – more than the populations of ...
Read OnWith the election of Donald Trump as our next President, is the focus off drug prices? Will things go back to business as usual? Will changes...
Read OnGovernment of India introduced the GST Tax solutions on July. THis seminar analysing its impact on Medical Industry and public life related with...
Learn More
